معرفی
Dr. Guangze Yang is an NHMRC Emerging Leadership Fellow at the School of Chemical Engineering within the Faculty of Sciences, Engineering and Technology at The University of Adelaide. His research program bridges fundamental nanomaterial science with practical applications in healthcare and industrial biotechnology, with a strong emphasis on translational potential. He leads a research group focused on developing advanced nanomaterials with high therapeutic and industrial value.
Dr. Yang's research interests center on the design and development of advanced nanomaterials for drug delivery, biomimetic systems, and sustainable technologies. His work specifically focuses on engineering polymeric and lipid nanoparticles with high drug-loading capacity, targeted delivery, and controlled release properties. He also investigates microfluidic-based nanoparticle synthesis and advanced drying techniques to improve stability and scalability. Beyond drug delivery, his research explores biofunctional materials including peptides, proteins, and stimuli-responsive systems, examining how material properties influence cellular interactions, immune responses, and therapeutic efficacy. His work extends to environmentally sustainable approaches in resource industries through biomolecules for mineral processing.
Analysis of Dr. Yang's recent publications reveals a strong focus on biomimetic and bioinspired nanomaterials, with particular emphasis on cell membrane-coated nanoparticles, peptide-based designs, and sustainable processing techniques. His work demonstrates a consistent progression toward increasingly sophisticated delivery systems with multi-functional capabilities, integrating computational approaches with experimental validation. The research spans both biomedical applications and sustainable industrial processes, reflecting his interdisciplinary approach.
- NHMRC Emerging Leadership Fellowship (2025-2029) for Innovative Chemoimmunotherapy for Metastatic Castration-Resistant Prostate Cancer
Dr. Yang actively mentors students and early-career researchers, contributing to the development of the next generation of scientists in nanotechnology and biomaterials. His NHMRC Fellowship project represents significant competitive funding that supports his innovative work in cancer therapy. He maintains active collaborations with both academic and industry partners, facilitating the translation of fundamental research into practical applications. His research program demonstrates a strong balance between fundamental scientific inquiry and applied technological development.
Dr. Yang's research group operates at the intersection of chemical engineering, nanotechnology, and biomedical science, utilizing advanced synthesis techniques, characterization methods, and biological evaluation to develop next-generation nanomaterials. The group maintains strong connections with clinical partners to ensure relevance to real-world medical challenges, while also working with industry to address sustainability challenges in resource processing.
